Valuation: Precision Therapeutics Inc

Market Cap 9.62Cr 8.57Cr 7.94Cr 7.18Cr 14Cr 907.87Cr 14Cr 95Cr 37Cr 477.21Cr 36Cr 35Cr 1.52TCr P/E 2026 *
-4.77x
P/E 2027 * -75.5x
Enterprise Value 9.62Cr 8.57Cr 7.94Cr 7.18Cr 14Cr 907.87Cr 14Cr 95Cr 37Cr 477.21Cr 36Cr 35Cr 1.52TCr EV / Sales 2026 *
1.59x
EV / Sales 2027 * 0.22x
Free-Float
93.93%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Precision Therapeutics Inc

Manager TitleAgeSince
Chief Executive Officer 57 09/02/2026
Director of Finance/CFO - 16/04/2026
President - 01/04/2026
Director TitleAgeSince
Director/Board Member 66 19/02/2020
Chairman 78 09/02/2026
Director/Board Member 60 09/07/2020
Change 5-day change 1-year change 3-year change Capi.($)
-7.56%-8.33% - - 9.62Cr
-0.21%-6.36%+49.00%+74.13% 6.63TCr
-0.22%+10.10%+12.77%+87.32% 5.29TCr
+0.82%+9.46%+7.75%+73.53% 5.48TCr
+3.28%+5.58%+26.51%+50.58% 4.41TCr
+0.51%+9.95%+22.40%+129.04% 4.37TCr
-1.15%+0.39%+263.21%+958.46% 4.21TCr
+0.10%+9.96%+17.15%+59.33% 3.4TCr
-1.30%-3.61%+37.37%+7.16% 2.62TCr
+0.69%+6.07%+31.89%+26.94% 2.34TCr
Average -0.40%+4.78%+52.01%+162.94% 4.31TCr
Weighted average by Cap. +0.43%+4.67%+51.34%+166.84%

Financials

2026 *2027 *
Net sales 6.04Cr 5.38Cr 4.98Cr 4.51Cr 8.5Cr 569.97Cr 8.6Cr 60Cr 23Cr 299.6Cr 23Cr 22Cr 954.69Cr 43Cr 38Cr 36Cr 32Cr 61Cr 4.07TCr 61Cr 426.63Cr 167.4Cr 2.14TCr 161.79Cr 158.43Cr 6.82TCr
Net income -4.14Cr -3.69Cr -3.42Cr -3.09Cr -5.82Cr -390.68Cr -5.89Cr -41Cr -16Cr -205.35Cr -16Cr -15Cr -654.37Cr -45L -40.1L -37.13L -33.6L -63.3L -42Cr -64.05L -4.45Cr -1.75Cr -22Cr -1.69Cr -1.65Cr -71Cr
Net Debt - -
Logo Precision Therapeutics Inc
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build.
Employees
-